CORD-19:2008f024274c53b0de1276f4047a6a641813fd98 / 633128-633329
Annnotations
{"target":"https://pubannotation.org/docs/sourcedb/CORD-19/sourceid/2008f024274c53b0de1276f4047a6a641813fd98","sourcedb":"CORD-19","sourceid":"2008f024274c53b0de1276f4047a6a641813fd98","text":"Ciclesonide nasal spray, at the doses evaluated, was safe and well tolerated in healthy and asymptomatic SAR subjects with no detectable effects of CIC on serum or urinary free cortisol concentrations.","tracks":[{"project":"CORD-19-Sentences","denotations":[{"id":"T35262","span":{"begin":0,"end":201},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"attributes":[{"subj":"T35262","pred":"source","obj":"CORD-19-Sentences"}]},{"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T33","span":{"begin":0,"end":201},"obj":"Sentence"}],"attributes":[{"subj":"T33","pred":"source","obj":"CORD-19_Custom_license_subset"}]},{"project":"CORD-19-PD-MONDO","denotations":[{"id":"T5892","span":{"begin":49,"end":52},"obj":"Disease"}],"attributes":[{"id":"A5892","pred":"mondo_id","subj":"T5892","obj":"http://purl.obolibrary.org/obo/MONDO_0010518"},{"subj":"T5892","pred":"source","obj":"CORD-19-PD-MONDO"}]},{"project":"CORD-19-PD-UBERON","denotations":[{"id":"T1242","span":{"begin":155,"end":160},"obj":"Body_part"}],"attributes":[{"id":"A1242","pred":"uberon_id","subj":"T1242","obj":"http://purl.obolibrary.org/obo/UBERON_0001977"},{"subj":"T1242","pred":"source","obj":"CORD-19-PD-UBERON"}]}],"config":{"attribute types":[{"pred":"source","value type":"selection","values":[{"id":"CORD-19-Sentences","color":"#ec93af","default":true},{"id":"CORD-19_Custom_license_subset","color":"#93caec"},{"id":"CORD-19-PD-MONDO","color":"#e4ec93"},{"id":"CORD-19-PD-UBERON","color":"#da93ec"}]}]}}